NCT03526939

Brief Summary

The overarching purpose of the proposed research is to demonstrate that high coverage implementation of combined prevention and care using an innovative approach will end the HIV epidemic among PWID in Haiphong, Viet Nam.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,546

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 17, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 16, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2020

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

3.2 years

First QC Date

May 4, 2018

Last Update Submit

March 2, 2021

Conditions

Keywords

Persons who inject drugsHIVHepatitis CVietnamBehavioral Intervention

Outcome Measures

Primary Outcomes (1)

  • Incidence of HIV in the PWID population

    Incidence of HIV in the PWID population to be calculated in person-years

    up to 48 months

Secondary Outcomes (4)

  • Number of participants with unsuppressed viral load

    up to 48 months

  • Cost-Effectiveness ratio as compared to baseline

    baseline, 3 years, 7 years, 10 years, and 20 years

  • Incremental costs averted

    up to 20 years

  • Lifetime medical costs

    up to 20 years

Study Arms (3)

HIV negative from RDS round 1

HIV negative PWID subjects from RDS round 1

HIV negative from RDS round 2

HIV negative PWID subjects from RDS round 2

HIV negative from RDS round 3

HIV negative PWID subjects from RDS round 3

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Residents of Haiphong Vietnam who currently are injecting drugs (heroin or methamphetamine) and at least 18 years of age

You may qualify if:

  • age 18 or older
  • capable of giving informed consent and participating in study activities
  • history of drug injection (confirmed by visual inspection or subject knowledge of injecting procedures)
  • currently using an injectable drug (heroin or methamphetamine
  • confirmed by urine test), not on MMT at initial recruitment
  • willingness to participate in follow up studies, and expecting to remain in Haiphong for 2 years

You may not qualify if:

  • less than 18 years of age
  • on MMT at initial recruitment
  • refusal to participate in follow-up studies
  • no history of drug injection
  • not currently using injectable drug (heroin or methamphetamine)
  • not capable of giving informed consent
  • those not expecting to remain in Haiphong for at least 2 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haiphong Medical University

Haiphong, Vietnam

Location

Related Publications (6)

  • Des Jarlais D, Khue PM, Feelemyer J, Arasteh K, Thi Huong D, Thi Hai Oanh K, Thi Giang H, Thi Tuyet Thanh N, Vinh VH, Heckathorn DD, Moles JP, Vallo R, Quillet C, Rapoud D, Michel L, Laureillard D, Hammett T, Nagot N. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Drug Alcohol Depend. 2018 Apr 1;185:106-111. doi: 10.1016/j.drugalcdep.2017.11.033. Epub 2018 Feb 2.

    PMID: 29432973BACKGROUND
  • Michel L, Des Jarlais DC, Duong Thi H, Khuat Thi Hai O, Pham Minh K, Peries M, Vallo R, Nham Thi Tuyet T, Hoang Thi G, Le Sao M, Feelemyer J, Vu Hai V, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Drug Alcohol Depend. 2017 Oct 1;179:198-204. doi: 10.1016/j.drugalcdep.2017.07.004. Epub 2017 Aug 2.

    PMID: 28800503BACKGROUND
  • Duong HT, Jarlais DD, Khuat OHT, Arasteh K, Feelemyer J, Khue PM, Giang HT, Laureillard D, Hai VV, Vallo R, Michel L, Moles JP, Nagot N; Drive Study Group. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. AIDS Behav. 2018 Jul;22(7):2161-2171. doi: 10.1007/s10461-017-1814-6.

    PMID: 28612212BACKGROUND
  • Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.

    PMID: 27178119BACKGROUND
  • Des Jarlais DC, Thi Huong D, Thi Hai Oanh K, Khue Pham M, Thi Giang H, Thi Tuyet Thanh N, Arasteh K, Feelemyer J, Hammett T, Peries M, Michel L, Vu Hai V, Roustide MJ, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Int J Drug Policy. 2016 Jun;32:50-6. doi: 10.1016/j.drugpo.2016.02.021. Epub 2016 Feb 27.

    PMID: 27006257BACKGROUND
  • Hammett TM, Trang NT, Oanh KTH, Huong NT, Giang LM, Huong DT, Nagot N, Des Jarlais DC. The relationship between health policy and public health interventions: a case study of the DRIVE project to "end" the HIV epidemic among people who inject drugs in Haiphong, Vietnam. J Public Health Policy. 2018 May;39(2):217-230. doi: 10.1057/s41271-017-0115-7.

    PMID: 29531303BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

serum and plasma aliquots and dried blood spots

MeSH Terms

Conditions

Hepatitis CPsychological Well-Being

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System DiseasesPersonal SatisfactionBehavior

Study Officials

  • Don Des Jarlais, PhD

    New York University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2018

First Posted

May 16, 2018

Study Start

October 17, 2016

Primary Completion

January 10, 2020

Study Completion

January 10, 2020

Last Updated

March 4, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations